We report here that the levels of several ceramide species, among them C16:0 ceramides, increase in the hypothalamus of mouse models of obesity and diabetes, likely attributable to increased CerS6-dependent ceramide synthesis in neurons. The gene discussed is CERS6; the disease is obesity disorder.